Literature DB >> 18196335

Correlation of multislice CT and histomorphology in HCC following TACE: predictors of outcome.

S Herber1, S Biesterfeld, U Franz, J Schneider, J Thies, M Schuchmann, C Düber, M B Pitton, G Otto.   

Abstract

The purpose of this study was to correlate histopathological with CT findings in patients suffering from hepatocellular carcinoma (HCC) eligible for orthotopic liver transplantation (OLT), with a special focus on the antitumoral effect of transarterial chemoembolization (TACE) therapy. A total of 42 consecutive patients suffering from HCC had been treated prior to OLT by means of TACE. TACE was carried out with a mixture of Lipiodol (10-20 ml) and mitomycin C (max. dosage, 10 mg). TACE was performed at 6- to 8-week intervals. Follow-up investigation included contrast-enhanced multislice CT controls and laboratory control. Liver explants were evaluated macroscopically and microscopically to determine the number and size of the tumor lesions as well as the degree of tumor necrosis. Necrosis was investigated in H&E-stained sections. The degree of necrosis was classified as follows: 0-25%, 26-50%, 51-75%, 75-99%, and complete necrosis. Two hundred thirty-one TACE procedures (5.5 +/- 2.9; range, 1-14) were performed. Mean tumor size in CT before and after TACE was 4.1 +/- 2.4 (range, 1.0-12.0 cm) and 2.7 +/- 1.2 (range, 1.0-6.0 cm; p < 0.001). Mean tumor number before and after TACE in CT was 2.5 +/- 1.5 (n = 105; range, 1-8) and 2.4 +/- 2.0 (n = 103; range, 1-6; p = 0.99). In the surgical specimen tumor size and tumor number were 2.8 +/- 1.6 (range, 1.0-7.0 cm; p = 0.78) and 1.9 +/- 1.2 (range, 1-7; p = 0.003). Mean tumor necrosis was 67.8% +/- 28.1%. Tumor necrosis was subtotal or complete in 17 of 42 (40.5%) patients. Tumor necrosis correlated significantly with the degree of arterial devascularization in CT (p = 0.001), the amount of Lipiodol washout (p = 0.002), and the number of tumor lesions (i.e., unifocal vs. multifocal). Furthermore, elevated serum levels of bilirubin (p = 0.005) and decreased albumin (p = 0.004) affected the local antitumoral effect. A poor necrosis rate (< 25%) significantly correlated with the number of TACE procedures accomplished (p = 0.023). In conclusion, TACE provided an acceptable local antitumoral effect in patients scheduled for liver transplantation. Tumor necrosis depended significantly on the degree of arterial devascularization and the accumulation of Lipiodol within the HCC lesions. Unifocal tumors and preserved liver function were positive predictors for a more favorable local antitumoral effect. Poor necrosis rates were found in patients with significant Lipiodol washout and who received a limited number of TACE procedures.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18196335     DOI: 10.1007/s00270-007-9270-8

Source DB:  PubMed          Journal:  Cardiovasc Intervent Radiol        ISSN: 0174-1551            Impact factor:   2.740


  21 in total

1.  Radiofrequency and microwave ablation in combination with transarterial chemoembolization induce equivalent histopathologic coagulation necrosis in hepatocellular carcinoma patients bridged to liver transplantation.

Authors:  Raj Vasnani; Michael Ginsburg; Osman Ahmed; Taral Doshi; John Hart; Helen Te; Thuong Gustav Van Ha
Journal:  Hepatobiliary Surg Nutr       Date:  2016-06       Impact factor: 7.293

2.  Intraprocedural 3D Quantification of Lipiodol Deposition on Cone-Beam CT Predicts Tumor Response After Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma.

Authors:  Zhijun Wang; Rongxin Chen; Rafael Duran; Yan Zhao; Gayane Yenokyan; Julius Chapiro; Rüdiger Schernthaner; Alessandro Radaelli; MingDe Lin; Jean-François Geschwind
Journal:  Cardiovasc Intervent Radiol       Date:  2015-05-23       Impact factor: 2.740

3.  Value of the portal venous phase in evaluation of treated hepatocellular carcinoma following transcatheter arterial chemoembolisation.

Authors:  A Lam; D Fernando; C C Sirlin; M Nayyar; S C Goodwin; D K Imagawa; C Lall
Journal:  Clin Radiol       Date:  2017-08-02       Impact factor: 2.350

4.  Revisiting the role of pathological analysis in transarterial chemoembolization-treated hepatocellular carcinoma after transplantation.

Authors:  Francesco Vasuri; Deborah Malvi; Francesca Rosini; Pamela Baldin; Michelangelo Fiorentino; Alexandro Paccapelo; Giorgio Ercolani; Antonio Daniele Pinna; Rita Golfieri; Antonio Maria Morselli-Labate; Walter Franco Grigioni; Antonia D'Errico-Grigioni
Journal:  World J Gastroenterol       Date:  2014-10-07       Impact factor: 5.742

5.  Imaging predictors of the response to transarterial chemoembolization in patients with hepatocellular carcinoma: a radiological-pathological correlation.

Authors:  Sharon W Kwan; Nicholas Fidelman; Elizabeth Ma; Robert K Kerlan; Francis Y Yao
Journal:  Liver Transpl       Date:  2012-06       Impact factor: 5.799

6.  Effects of pre-operative transcatheter arterial chemoembolization for resectable hepatocellular carcinoma: Implication of circulating cancer cells by detection of α-fetoprotein mRNA.

Authors:  Masahiro Murakami; Hiroaki Nagano; Shogo Kobayashi; Hiroshi Wada; Masato Nakamura; Shigeru Marubashi; Hidetoshi Eguchi; Yutaka Takeda; Masahiro Tanemura; Koji Umeshita; Yuichiro Doki; Masaki Mori
Journal:  Exp Ther Med       Date:  2010-05-01       Impact factor: 2.447

7.  Metabolic restaging of hepatocellular carcinoma using whole-body F-FDG PET/CT.

Authors:  Long Sun; Yong-Song Guan; Wei-Min Pan; Zuo-Ming Luo; Ji-Hong Wei; Long Zhao; Hua Wu
Journal:  World J Hepatol       Date:  2009-10-31

8.  Sequential intra-arterial therapy and portal vein embolization is feasible and safe in patients with advanced hepatic malignancies.

Authors:  Peter D Peng; Omar Hyder; Mark Bloomston; Hugo Marques; Celia Corona-Villalobos; Elijah Dixon; Carlo Pulitano; Kenzo Hirose; Richard D Schulick; Eduardo Barroso; Luca Aldrighetti; Michael Choti; Feng Shen; Ihab Kamel; Jean-Francois H Geschwind; Timothy M Pawlik
Journal:  HPB (Oxford)       Date:  2012-05-31       Impact factor: 3.647

9.  Pattern of retained contrast on immediate postprocedure computed tomography (CT) after particle embolization of liver tumors predicts subsequent treatment response.

Authors:  Xiaodong Wang; Joseph P Erinjeri; Xiaoyu Jia; Mithat Gonen; Karen T Brown; Constantinos T Sofocleous; George I Getrajdman; Lynn A Brody; Raymond H Thornton; Majid Maybody; Ann M Covey; Robert H Siegelbaum; William Alago; Stephen B Solomon
Journal:  Cardiovasc Intervent Radiol       Date:  2012-11-14       Impact factor: 2.740

10.  Does Enhancement or Perfusion on Preprocedure CT Predict Outcomes After Embolization of Hepatocellular Carcinoma?

Authors:  Alessandra Borgheresi; Adrian Gonzalez-Aguirre; Karen T Brown; George I Getrajdman; Joseph P Erinjeri; Anne Covey; Hooman Yarmohammadi; Etay Ziv; Constantinos T Sofocleous; Franz Edward Boas
Journal:  Acad Radiol       Date:  2018-03-27       Impact factor: 3.173

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.